BACKGROUND: The GABAergic neuroactive steroid (3α,5α)-3-hydroxy-pregnan-20-one (3α,5α-THP; allopregnanolone) has been studied during withdrawal from ethanol (EtOH) in humans, rats, and mice. Serum 3α,5α-THP levels decreased, and brain levels were not altered following acute EtOH administration (2 g/kg) in male C57BL/6J mice; however, the effects of chronic intermittent ethanol (CIE) exposure on 3α,5α-THP levels have not been examined. Given that CIE exposure changes subsequent voluntary EtOH drinking in a time-dependent fashion following repeated cycles of EtOH exposure, we conducted a time-course analysis of CIE effects on 3α,5α-THP levels in specific brain regions known to influence drinking behavior. METHODS: Adult male C57BL/6J mice were exposed to 4 cycles of CIE to induce EtOH dependence. All mice were sacrificed and perfused at 1 of 2 time points, 8 or 72 hours following the final exposure cycle. Free-floating brain sections (40 μm; 3 to 5 sections/region/animal) were immunostained and analyzed to determine relative levels of cellular 3α,5α-THP. RESULTS: Withdrawal from CIE exposure produced time-dependent and region-specific effects on immunohistochemical detection of 3α,5α-THP levels across cortical and limbic brain regions. A transient reduction in 3α,5α-THP immunoreactivity was observed in the central nucleus of the amygdala 8 hours after withdrawal from CIE (-31.4 ± 9.3%). Decreases in 3α,5α-THP immunoreactivity were observed 72 hours following withdrawal in the medial prefrontal cortex (-25.0 ± 9.3%), nucleus accumbens core (-29.9 ± 6.6%), and dorsolateral striatum (-18.5 ± 6.0%), while an increase was observed in the CA3 pyramidal cell layer of the hippocampus (+42.8 ± 19.5%). Sustained reductions in 3α,5α-THP immunoreactivity were observed at both time points in the lateral amygdala (8 hours -28.3 ± 12.8%; 72 hours -27.5 ± 12.4%) and in the ventral tegmental area (8 hours -26.5 ± 9.9%; 72 hours -31.6 ± 13.8%). CONCLUSIONS: These data suggest that specific neuroadaptations in 3α,5α-THP levels may be present in regions of brain that mediate anxiety, stress, and reinforcement relevant to EtOH dependence. The changes that occur at different time points likely modulate neurocircuitry involved in EtOH withdrawal as well as the elevated drinking observed after CIE exposure.
BACKGROUND: The GABAergic neuroactive steroid (3α,5α)-3-hydroxy-pregnan-20-one (3α,5α-THP; allopregnanolone) has been studied during withdrawal from ethanol (EtOH) in humans, rats, and mice. Serum 3α,5α-THP levels decreased, and brain levels were not altered following acute EtOH administration (2 g/kg) in male C57BL/6J mice; however, the effects of chronic intermittent ethanol (CIE) exposure on 3α,5α-THP levels have not been examined. Given that CIE exposure changes subsequent voluntary EtOH drinking in a time-dependent fashion following repeated cycles of EtOH exposure, we conducted a time-course analysis of CIE effects on 3α,5α-THP levels in specific brain regions known to influence drinking behavior. METHODS: Adult male C57BL/6J mice were exposed to 4 cycles of CIE to induce EtOH dependence. All mice were sacrificed and perfused at 1 of 2 time points, 8 or 72 hours following the final exposure cycle. Free-floating brain sections (40 μm; 3 to 5 sections/region/animal) were immunostained and analyzed to determine relative levels of cellular 3α,5α-THP. RESULTS: Withdrawal from CIE exposure produced time-dependent and region-specific effects on immunohistochemical detection of 3α,5α-THP levels across cortical and limbic brain regions. A transient reduction in 3α,5α-THP immunoreactivity was observed in the central nucleus of the amygdala 8 hours after withdrawal from CIE (-31.4 ± 9.3%). Decreases in 3α,5α-THP immunoreactivity were observed 72 hours following withdrawal in the medial prefrontal cortex (-25.0 ± 9.3%), nucleus accumbens core (-29.9 ± 6.6%), and dorsolateral striatum (-18.5 ± 6.0%), while an increase was observed in the CA3 pyramidal cell layer of the hippocampus (+42.8 ± 19.5%). Sustained reductions in 3α,5α-THP immunoreactivity were observed at both time points in the lateral amygdala (8 hours -28.3 ± 12.8%; 72 hours -27.5 ± 12.4%) and in the ventral tegmental area (8 hours -26.5 ± 9.9%; 72 hours -31.6 ± 13.8%). CONCLUSIONS: These data suggest that specific neuroadaptations in 3α,5α-THP levels may be present in regions of brain that mediate anxiety, stress, and reinforcement relevant to EtOH dependence. The changes that occur at different time points likely modulate neurocircuitry involved in EtOH withdrawal as well as the elevated drinking observed after CIE exposure.
Authors: A L Morrow; G C Janis; M J VanDoren; D B Matthews; H H Samson; P H Janak; K A Grant Journal: Alcohol Clin Exp Res Date: 1999-12 Impact factor: 3.455
Authors: Marco Diana; Mark Brodie; Annalisa Muntoni; Maria C Puddu; Giuliano Pillolla; Scott Steffensen; Saturnino Spiga; Hilary J Little Journal: Alcohol Clin Exp Res Date: 2003-02 Impact factor: 3.455
Authors: Mariangela Serra; M Giuseppina Pisu; Ivan Floris; Valeria Cara; Robert H Purdy; Giovanni Biggio Journal: J Neurochem Date: 2003-04 Impact factor: 5.372
Authors: Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn Journal: Neuroscience Date: 2018-12-02 Impact factor: 3.590
Authors: Matthew C Beattie; Antoniette M Maldonado-Devincci; Patrizia Porcu; Todd K O'Buckley; James B Daunais; Kathleen A Grant; A Leslie Morrow Journal: Addict Biol Date: 2015-12-02 Impact factor: 4.280
Authors: Jason B Cook; David F Werner; Antoniette M Maldonado-Devincci; Maggie N Leonard; Kristen R Fisher; Todd K O'Buckley; Patrizia Porcu; Thomas J McCown; Joyce Besheer; Clyde W Hodge; A Leslie Morrow Journal: J Neurosci Date: 2014-04-23 Impact factor: 6.167
Authors: Jeremiah P Jensen; Michelle A Nipper; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn Journal: Psychopharmacology (Berl) Date: 2017-06-29 Impact factor: 4.530
Authors: Ahmet Sait Hasirci; Antoniette M Maldonado-Devincci; Matthew C Beattie; Todd K O'Buckley; A Leslie Morrow Journal: Alcohol Clin Exp Res Date: 2017-01-09 Impact factor: 3.455
Authors: Megan K Mulligan; Khyobeni Mozhui; Ashutosh K Pandey; Maren L Smith; Suzhen Gong; Jesse Ingels; Michael F Miles; Marcelo F Lopez; Lu Lu; Robert W Williams Journal: Alcohol Date: 2016-10-15 Impact factor: 2.405
Authors: Patrizia Porcu; Todd K O'Buckley; Marcelo F Lopez; Howard C Becker; Michael F Miles; Robert W Williams; A Leslie Morrow Journal: Alcohol Date: 2016-11-10 Impact factor: 2.405
Authors: Kristen E Pleil; Emily G Lowery-Gionta; Nicole A Crowley; Chia Li; Catherine A Marcinkiewcz; Jamie H Rose; Nora M McCall; Antoniette M Maldonado-Devincci; A Leslie Morrow; Sara R Jones; Thomas L Kash Journal: Neuropharmacology Date: 2015-07-16 Impact factor: 5.250
Authors: P Porcu; A M Barron; C A Frye; A A Walf; S-Y Yang; X-Y He; A L Morrow; G C Panzica; R C Melcangi Journal: J Neuroendocrinol Date: 2016-02 Impact factor: 3.627
Authors: Matthew C Beattie; Christopher S Reguyal; Patrizia Porcu; James B Daunais; Kathleen A Grant; A Leslie Morrow Journal: Alcohol Clin Exp Res Date: 2017-12-05 Impact factor: 3.455